United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51655-484_4a1a0f52-62a3-c5b7-e063-6394a90a302a
- Product NDC
- 51655-484
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Northwind Health Company, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201123
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE, PLASTIC (51655-484-26) · 51655-484-26
- 30 TABLET in 1 BOTTLE, PLASTIC (51655-484-52) · 51655-484-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →